Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | GERN |
---|---|---|
09:32 ET | 149156 | 4.425 |
09:34 ET | 28088 | 4.425 |
09:36 ET | 18944 | 4.42 |
09:38 ET | 65359 | 4.42 |
09:39 ET | 12634 | 4.4 |
09:41 ET | 28732 | 4.385 |
09:43 ET | 12521 | 4.395 |
09:45 ET | 50293 | 4.3799 |
09:48 ET | 17465 | 4.365 |
09:50 ET | 11817 | 4.365 |
09:52 ET | 56768 | 4.395 |
09:54 ET | 14429 | 4.39 |
09:56 ET | 30243 | 4.4 |
09:57 ET | 5800 | 4.395 |
09:59 ET | 4562 | 4.4 |
10:01 ET | 13994 | 4.405 |
10:03 ET | 10762 | 4.405 |
10:06 ET | 19630 | 4.395 |
10:08 ET | 34282 | 4.39 |
10:10 ET | 25979 | 4.38 |
10:12 ET | 73621 | 4.37 |
10:14 ET | 253498 | 4.375 |
10:15 ET | 4520 | 4.37 |
10:17 ET | 121899 | 4.375 |
10:19 ET | 31852 | 4.365 |
10:21 ET | 41129 | 4.365 |
10:24 ET | 12126 | 4.35 |
10:26 ET | 46365 | 4.355 |
10:28 ET | 19814 | 4.3502 |
10:30 ET | 27814 | 4.34 |
10:32 ET | 18394 | 4.342 |
10:33 ET | 58477 | 4.32 |
10:35 ET | 19579 | 4.34 |
10:37 ET | 30767 | 4.32 |
10:39 ET | 25264 | 4.32 |
10:42 ET | 37101 | 4.31 |
10:44 ET | 28796 | 4.315 |
10:46 ET | 21038 | 4.305 |
10:48 ET | 49108 | 4.3 |
10:50 ET | 51273 | 4.29 |
10:51 ET | 22211 | 4.3002 |
10:53 ET | 33260 | 4.31 |
10:55 ET | 10235 | 4.33 |
10:57 ET | 43464 | 4.31 |
11:00 ET | 10631 | 4.315 |
11:02 ET | 50291 | 4.32 |
11:04 ET | 28587 | 4.315 |
11:06 ET | 48231 | 4.31 |
11:08 ET | 25843 | 4.32 |
11:09 ET | 19200 | 4.325 |
11:11 ET | 14633 | 4.31 |
11:13 ET | 70015 | 4.31 |
11:15 ET | 65524 | 4.31 |
11:18 ET | 128054 | 4.325 |
11:20 ET | 10291 | 4.33 |
11:22 ET | 23406 | 4.36 |
11:24 ET | 130602 | 4.36 |
11:26 ET | 24269 | 4.36 |
11:27 ET | 62200 | 4.335 |
11:29 ET | 19770 | 4.325 |
11:31 ET | 12205 | 4.325 |
11:33 ET | 25518 | 4.325 |
11:36 ET | 5810 | 4.325 |
11:38 ET | 3543 | 4.33 |
11:40 ET | 21554 | 4.325 |
11:42 ET | 5380 | 4.31 |
11:44 ET | 11034 | 4.32 |
11:45 ET | 18266 | 4.335 |
11:47 ET | 4318 | 4.33 |
11:49 ET | 5184 | 4.33 |
11:51 ET | 19155 | 4.34 |
11:54 ET | 2055 | 4.345 |
11:56 ET | 32009 | 4.35 |
11:58 ET | 26963 | 4.345 |
12:00 ET | 2564 | 4.345 |
12:02 ET | 12203 | 4.33 |
12:03 ET | 1918 | 4.33 |
12:05 ET | 16252 | 4.325 |
12:07 ET | 4548 | 4.325 |
12:09 ET | 3424 | 4.325 |
12:12 ET | 5824 | 4.325 |
12:14 ET | 3204 | 4.325 |
12:16 ET | 4569 | 4.325 |
12:18 ET | 9882 | 4.32 |
12:20 ET | 50419 | 4.32 |
12:21 ET | 38247 | 4.325 |
12:23 ET | 23488 | 4.325 |
12:25 ET | 31088 | 4.31 |
12:27 ET | 19545 | 4.315 |
12:30 ET | 43037 | 4.3163 |
12:32 ET | 7693 | 4.31 |
12:34 ET | 2700 | 4.31 |
12:36 ET | 3122 | 4.31 |
12:38 ET | 6802 | 4.31 |
12:39 ET | 38856 | 4.2901 |
12:41 ET | 16715 | 4.295 |
12:43 ET | 173905 | 4.305 |
12:45 ET | 165867 | 4.32 |
12:48 ET | 14216 | 4.3 |
12:50 ET | 16101 | 4.28 |
12:52 ET | 5593 | 4.29 |
12:54 ET | 113694 | 4.285 |
12:56 ET | 104609 | 4.32 |
12:57 ET | 95101 | 4.32 |
12:59 ET | 42085 | 4.335 |
01:01 ET | 3195 | 4.335 |
01:03 ET | 22703 | 4.345 |
01:06 ET | 23685 | 4.355 |
01:08 ET | 22112 | 4.34 |
01:10 ET | 59279 | 4.325 |
01:12 ET | 6222 | 4.33 |
01:14 ET | 40424 | 4.325 |
01:15 ET | 165169 | 4.35 |
01:17 ET | 10743 | 4.345 |
01:19 ET | 17250 | 4.34 |
01:21 ET | 23388 | 4.335 |
01:24 ET | 115696 | 4.325 |
01:26 ET | 17680 | 4.325 |
01:28 ET | 25760 | 4.33 |
01:30 ET | 17547 | 4.325 |
01:32 ET | 42643 | 4.295 |
01:33 ET | 38620 | 4.295 |
01:35 ET | 2573 | 4.29 |
01:37 ET | 21039 | 4.285 |
01:39 ET | 27678 | 4.285 |
01:42 ET | 18558 | 4.29 |
01:44 ET | 3850 | 4.29 |
01:46 ET | 4285 | 4.285 |
01:48 ET | 15347 | 4.2901 |
01:50 ET | 50209 | 4.285 |
01:51 ET | 175880 | 4.2899 |
01:53 ET | 20288 | 4.295 |
01:55 ET | 54256 | 4.305 |
01:57 ET | 15365 | 4.305 |
02:00 ET | 69842 | 4.305 |
02:02 ET | 38966 | 4.3 |
02:04 ET | 37558 | 4.305 |
02:06 ET | 3354 | 4.305 |
02:08 ET | 19311 | 4.32 |
02:09 ET | 5200 | 4.32 |
02:11 ET | 75037 | 4.325 |
02:13 ET | 38515 | 4.34 |
02:15 ET | 33019 | 4.34 |
02:18 ET | 37333 | 4.34 |
02:20 ET | 11387 | 4.34 |
02:22 ET | 10389 | 4.34 |
02:24 ET | 3299 | 4.34 |
02:26 ET | 8835 | 4.34 |
02:27 ET | 5041 | 4.34 |
02:29 ET | 50026 | 4.34 |
02:31 ET | 39803 | 4.345 |
02:33 ET | 19824 | 4.345 |
02:36 ET | 5456 | 4.34 |
02:38 ET | 10491 | 4.345 |
02:40 ET | 2795 | 4.345 |
02:42 ET | 5197 | 4.345 |
02:44 ET | 71069 | 4.375 |
02:45 ET | 9419 | 4.375 |
02:47 ET | 2410 | 4.375 |
02:49 ET | 6016 | 4.375 |
02:51 ET | 36483 | 4.365 |
02:54 ET | 2700 | 4.365 |
02:56 ET | 47698 | 4.355 |
02:58 ET | 3883 | 4.355 |
03:00 ET | 122934 | 4.38 |
03:02 ET | 16688 | 4.385 |
03:03 ET | 248994 | 4.405 |
03:05 ET | 3900 | 4.41 |
03:07 ET | 138712 | 4.43 |
03:09 ET | 25219 | 4.44 |
03:12 ET | 11099 | 4.44 |
03:14 ET | 4611 | 4.435 |
03:16 ET | 63756 | 4.44 |
03:18 ET | 3439 | 4.44 |
03:20 ET | 21744 | 4.43 |
03:21 ET | 80850 | 4.44 |
03:23 ET | 2100 | 4.44 |
03:25 ET | 19641 | 4.45 |
03:27 ET | 4000 | 4.45 |
03:30 ET | 3824 | 4.445 |
03:32 ET | 18805 | 4.45 |
03:34 ET | 4747 | 4.445 |
03:36 ET | 143986 | 4.44 |
03:38 ET | 51626 | 4.45 |
03:39 ET | 6447 | 4.445 |
03:41 ET | 48617 | 4.46 |
03:43 ET | 75630 | 4.465 |
03:45 ET | 55398 | 4.455 |
03:48 ET | 5825 | 4.455 |
03:50 ET | 81255 | 4.46 |
03:52 ET | 32188 | 4.445 |
03:54 ET | 266420 | 4.44 |
03:56 ET | 253040 | 4.445 |
03:57 ET | 154032 | 4.441 |
03:59 ET | 411486 | 4.45 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Geron Corp | 2.7B | -12.8x | --- |
SpringWorks Therapeutics Inc | 2.7B | -7.0x | --- |
Xenon Pharmaceuticals Inc | 2.8B | -13.5x | --- |
MoonLake Immunotherapeutics | 2.5B | -53.6x | --- |
IDEAYA Biosciences Inc | 2.7B | -17.4x | --- |
Iovance Biotherapeutics Inc | 2.4B | -4.5x | --- |
Geron Corporation is a late-stage clinical biopharmaceutical company developing investigational first-in-class telomerase inhibitor, imetelstat, to treat hematologic malignancies. The Company is engaged in the development of therapeutic products for oncology. Its lead indication for imetelstat is in Low or Intermediate-1 risk myelodysplastic syndromes. It is developing imetelstat for the treatment of several myeloid hematologic malignancies, including a Phase 3 clinical trial, named IMpactMF, in relapsed/refractory myelofibrosis (MF) with overall survival as the primary endpoint, that is enrolling patients. It is also conducting a Phase 1 combination therapy clinical trial, named IMproveMF, in first-line Intermediate-1, Intermediate-2 or High-Risk myelofibrosis, or frontline MF, that is enrolling patients and imetelstat is being studied in an investigator-led Phase 2 clinical trial, named IMpress, in Intermediate-2 or High-Risk myelodysplastic syndromes and acute myeloid leukemia.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.7B |
---|---|
Revenue (TTM) | $520.0K |
Shares Outstanding | 593.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.49 |
EPS | $-0.35 |
Book Value | $0.46 |
P/E Ratio | -12.8x |
Price/Sales (TTM) | 5,155.7 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -40,381.92% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.